We are live on ! Find out more
ProShare Advisors

ProShare Advisors Portfolio holdings

AUM $67.5B
1-Year Est. Return 28.09%
This Fund
S&P 500
This Quarter Est. Return
+12.13%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$32.7B
AUM Growth
+$651M
Cap. Flow
-$2.75B
Cap. Flow %
-8.41%
Top 10 Hldgs %
20.41%
Holding
1,997
New
181
Increased
978
Reduced
793
Closed
44

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$420M
2
MSFT icon
Microsoft
MSFT
+$382M
3
AMZN icon
Amazon
AMZN
+$209M
4
NVDA icon
NVIDIA
NVDA
+$163M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$117M

Sector Composition

Rank Sector Weight
1 Technology 25.56%
2 Industrials 12.61%
3 Consumer Staples 11.87%
4 Financials 10.22%
5 Consumer Discretionary 9.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ASTH icon
1351
Astrana Health
ASTH
$2B
$307K ﹤0.01%
8,015
+1,513
+23% +$50.4K
JOBY icon
1352
Joby Aviation
JOBY
$6.82B
$307K ﹤0.01%
46,161
+9,934
+27% +$61.2K
TTMI icon
1353
TTM Technologies
TTMI
$13.6B
$307K ﹤0.01%
19,415
+3,806
+24% +$53K
AVDX
1354
DELISTED
AvidXchange
AVDX
$307K ﹤0.01%
24,739
+5,323
+27% +$53.2K
LEGN icon
1355
Legend Biotech
LEGN
$4.3B
$306K ﹤0.01%
5,091
-118
-2% -$7.48K
INSW icon
1356
International Seaways
INSW
$4.57B
$306K ﹤0.01%
6,729
+1,448
+27% +$66.6K
HIMX
1357
Himax Technologies
HIMX
$2.2B
$306K ﹤0.01%
50,345
+5,977
+13% +$34.5K
EYE icon
1358
National Vision
EYE
$1.6B
$306K ﹤0.01%
14,598
+2,763
+23% +$49K
CLDX icon
1359
Celldex Therapeutics
CLDX
$2.77B
$305K ﹤0.01%
+7,690
New +$226K
G icon
1360
Genpact
G
$5.3B
$305K ﹤0.01%
8,779
-230
-3% -$7.93K
VGR
1361
DELISTED
Vector Group Ltd.
VGR
$305K ﹤0.01%
27,013
+5,166
+24% +$56K
LKFN icon
1362
Lakeland Financial Corp
LKFN
$1.52B
$305K ﹤0.01%
+4,675
New +$258K
LGND icon
1363
Ligand Pharmaceuticals
LGND
$6.02B
$305K ﹤0.01%
4,264
+599
+16% +$35.3K
FWRD icon
1364
Forward Air
FWRD
$482M
$304K ﹤0.01%
4,830
+691
+17% +$46.5K
CR icon
1365
Crane Co
CR
$13.1B
$304K ﹤0.01%
2,569
-68
-3% -$6.85K
ENVA icon
1366
Enova International
ENVA
$5.91B
$303K ﹤0.01%
5,481
+840
+18% +$38.8K
H icon
1367
Hyatt Hotels
H
$17.6B
$303K ﹤0.01%
+2,326
New +$264K
NTNX icon
1368
Nutanix
NTNX
$14.9B
$303K ﹤0.01%
6,353
-1,701
-21% -$68.8K
VUZI icon
1369
Vuzix
VUZI
$190M
$303K ﹤0.01%
145,261
+76,116
+110% +$207K
KN icon
1370
Knowles
KN
$3.22B
$302K ﹤0.01%
16,886
+3,175
+23% +$49.3K
COHR icon
1371
Coherent
COHR
$55.2B
$302K ﹤0.01%
6,934
-6,002
-46% -$216K
HTGC icon
1372
Hercules Capital
HTGC
$2.94B
$302K ﹤0.01%
18,099
-905
-5% -$14.3K
B
1373
DELISTED
Barnes Group Inc.
B
$301K ﹤0.01%
9,236
+1,740
+23% +$49.7K
PTGX icon
1374
Protagonist Therapeutics
PTGX
$8.75B
$301K ﹤0.01%
13,139
+1,957
+18% +$34.2K
RLJ icon
1375
RLJ Lodging Trust
RLJ
$1.87B
$301K ﹤0.01%
25,665
+5,308
+26% +$55.1K

Similar funds

ProShare Advisors's Q4 2023 Portfolio in Review

As of Q4 2023, ProShare Advisors held 1,997 positions worth $32.7B, up 2% from $32.1B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

ProShare Advisors withdrew a net $2.75B in Q4 2023, closing 44 positions and reducing 793 holdings. Its most notable exit was Seagen Inc. Common Stock, an estimated $40.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 26% a quarter earlier, followed by Industrials and Consumer Staples.

Against the trend, ProShare Advisors opened a new position in DoorDash worth $28.6M.

  • ProShare Advisors's largest Q4 2023 buy was DoorDash: 289,583 shares worth $28.6M.
  • ProShare Advisors added most to Kenvue in Q4 2023, an estimated $146M increase.
  • ProShare Advisors's biggest Q4 2023 reduction was Apple, cutting an estimated $420M.
  • ProShare Advisors fully exited Seagen Inc. Common Stock in Q4 2023, selling an estimated $40.1M.
  • ProShare Advisors's ten largest holdings make up 20% of its $32.7B portfolio in Q4 2023.
  • ProShare Advisors opened 181 new positions and closed 44 in Q4 2023.
  • ProShare Advisors's portfolio value rose 2% quarter-over-quarter to $32.7B.

Based on ProShare Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.